| DaVita's catheter-reduction program lowers CVC rates in hemodialysis patients - News-Medical.net |
|
|
News-Medical.net DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), today announced that the company has made landmark progress in reducing "Day 90+" patient |